Our clinical fellowship training in endocrinology, diabetes and metabolism is accredited by the Accreditation Council for Graduate Medical Education (ACGME). Our program aspires to providing excellent training in clinical endocrinology, diabetes and metabolic bone diseases; to motivate and inspire innovative clinical and basic research in endocrinology, diabetes and bone biology; and to prepare the trainees to become academic physicians/scientists and future leaders of endocrine research, education and practice. To achieve this objective, our program was uniquely designed into 2 components. The first component is for 2 years of intensive clinical training. The second component is for 2 years of a research intensive training (at least 75% of time) and small fraction of clinical activity as a clinical faculty (up to 25% of time). When a fellow joins our program he/she commits for a total of 4 years. When we interview our candidates we select those who show evidence of clinical excellence, research interest and academic commitment. The two components of the program are:
ACGME-Accredited Endocrine Fellowship for 2 years:
The objective from this training is to prepares the trainee to become skilled in clinical endocrinology and make him/her eligible to sit for the ABIM certifying examination in Endocrinology, Diabetes and Metabolism. During the first year, the trainee is exposed to extensive clinical training in outpatient and inpatient settings, plus didactic core curriculum lectures, journal clubs and case discussion. During the second year, the clinical duties is decreased and the trainee is able to devote more time for a research project. The trainee is expected to make good progress in the selected project before he/she become eligible for the ABIM board by the end of the second year of training. The fellow is expected to take and pass the next possible board certifying examination in Endocrinology, Diabetes and Metabolic Diseases.
Research (75% of time) and Clinical Faculty (25% of time) for 2 years:
The objective is to develop experience in endocrine research (clinical, translational and/or basic) and become successful endocrine investigators and scholars. There shall be a protected research time (>75%) supported by a T32 training grant from the National Institutes of Health or by institutional resources. During the 2 years of research-intensive program the trainees shall publish their research findings and write research grant proposals mentored by a faculty of their choice.
During this period successful trainees shall have the status of a clinical faculty as Attending Physician for 25% of his/her time with an opportunity to supervise clinical trainees (up to 1 day or 2 half-days of outpatient clinics per week and up to 2 months of inpatient rounding per year).
The combined salary during this period shall be approximately twice that of the clinical fellow's salary.
At the conclusion of 4 years the trainee shall become capable of competing for academic positions both within the institution and nationwide as a physician scientist armed with clinical and research skills, potential publication records and grant application, and academic experience as Instructor in Medicine. Therefore, we highly encourage individuals with academic ambition to apply.
How to Apply: Applications are accepted through the Electronic Residency Application Service (ERAS).
Selection Criteria: Applicants are evaluated based on 1) commitment to academic career; 2) interest in endocrine research; 3) evidence of scholarly work (records of research activity and/or publications); 4) evidence of excellent clinical training during residency program; and 5) USMLE scores and/or ABIM certification.
Because our program requires commitment for 4 years (2 years of clinical fellowship and 2 years of a combined position in research training and clinical faculty) we opted not to join the electronic matching program. After we interview all our applicants we select our fellows, we offer them the available positions, which, if they accept, require them to withdraw from the match.